Neurelis, Inc.
Pharmaceutical ManufacturingCalifornia, United States51-200 Employees
Neurelis, Inc., is dedicated to innovating life-changing therapeutics that help people with neurological conditions gain greater control over their journeys.
Market Engagement Neurelis actively participates in epilepsy awareness events such as Epilepsy Awareness Day and Sofie's Journey Expo, indicating a strong commitment to engaging with the epilepsy community and healthcare providers, which presents opportunities for targeted outreach and collaboration.
Innovative Therapeutics The company's focus on developing life-changing neurological therapeutics, including VALTOCO and investigational drugs like NRL-1049, aligns with the needs of healthcare providers seeking advanced treatment options, offering potential for partnerships or sales of related medical devices and services.
Growth & Funding With revenue estimated between 100M and 250M and secured funding of 114M, Neurelis demonstrates financial stability andgrowth potential, making it a viable client for strategic partnerships, research collaborations, or sales of technology solutions.
Technology Utilization Neurelis utilizes advanced digital tools such as NetSuite and Google Maps, suggesting a tech-savvy organization open to deploying innovative software solutions for operations, supply chain management, or customer engagement endeavors.
Leadership & Recognition The leadership's strategic focus and recent awards like the PM360 Gold Award highlight a forward-thinking company with a strong market presence, presenting an ideal opportunity for sales of consulting, promotional, or clinical support services tailored to dynamic pharmaceutical firms.
Neurelis, Inc. uses 8 technology products and services including NetSuite, jQuery Migrate, Google Maps, and more. Explore Neurelis, Inc.'s tech stack below.
| Neurelis, Inc. Email Formats | Percentage |
| FLast@neurelis.com | 98% |
| Last@neurelis.com | 1% |
| F.Last@neurelis.com | 1% |
Pharmaceutical ManufacturingCalifornia, United States51-200 Employees
Neurelis, Inc., is dedicated to innovating life-changing therapeutics that help people with neurological conditions gain greater control over their journeys.
Neurelis, Inc. has raised a total of $114M of funding over 9 rounds. Their latest funding round was raised on Mar 10, 2021 in the amount of $114M.
Neurelis, Inc.'s revenue is estimated to be in the range of $100M$250M
Neurelis, Inc. has raised a total of $114M of funding over 9 rounds. Their latest funding round was raised on Mar 10, 2021 in the amount of $114M.
Neurelis, Inc.'s revenue is estimated to be in the range of $100M$250M